Stay updated on Pembrolizumab Combo in Metastatic NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Metastatic NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Metastatic NSCLC Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Removed core topic labels like 'Lung cancer' and related topics, affecting the trial's disease focus and discoverability. Added UI elements such as 'Show glossary' and QC-related metadata like 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'.
    Difference
    0.2%
    Check dated 2026-01-28T04:48:21.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    Added 'Lung cancer' as a related topic and a MedlinePlus Genetics link under Related Topics. These additions improve discoverability without altering study details or results.
    Difference
    0.1%
    Check dated 2026-01-21T04:44:12.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added; Lung cancer and related topics (MedlinePlus Genetics) were removed, along with Revision: v3.3.3.
    Difference
    0.1%
    Check dated 2026-01-14T03:01:31.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Added related topics: Lung cancer and MedlinePlus Genetics to the page to link to broader information.
    Difference
    0.1%
    Check dated 2026-01-07T01:20:51.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The study's locations section was expanded to include new sites across multiple countries and states, and several prior location entries were removed. A revision tag (Revision: v3.3.3) is also noted on the page.
    Difference
    2%
    Check dated 2025-12-23T17:27:37.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Lung cancer and related topics (MedlinePlus Genetics) were added and the Publications note now states that publications are automatically filled from PubMed, with the revision tag updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T17:51:48.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Metastatic NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Metastatic NSCLC Clinical Trial page.